UTHR - Latest News
United Therapeutics Corporation (UTHR), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $25.18B. Trailing twelve-month P/E ratio is 20.51. Beta to the broader market is 0.56.
The article list below shows the most recent UTHR headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent UTHR Headlines
United Therapeutics Corporation Announces Participation at Upcoming Investor Conferences
gurufocus.com - Nov 9, 2026
United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer, will provide an overview an
Buy, Sell, or Hold? Monday’s Top Upgrades and Downgrades: Advanced Micro Devices, Airbnb, DraftKings, L3 Harris Technologies, Molson-Coors, Nvidia, Take-Two Interactive, Uber Technologies, and More
247wallst.com - Nov 9, 2026
Nvidia just lost a vote of confidence while AMD earned a $600 target, and Wall Street's chip debate is splitting wide open. Add a Fed rate hike loomi
United Therapeutics Corporation Announces Participation at Upcoming Investor Conferences
businesswire.com - Nov 9, 2026
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.
What United Therapeutics (UTHR) Said on Its Q3 Earnings Call
marketbeat.com - Nov 4, 2026
United Therapeutics NASDAQ: UTHR reported record third-quarter 2026 revenue of $833 million, driven in part by record Tyvaso sales of $504 million, wh
United Therapeutics Corporation (UTHR) Q3 2026 Earnings Call Transcript
seekingalpha.com - Nov 4, 2026
United Therapeutics Corporation (UTHR) Q3 2026 Earnings Call Transcript
How News Affects UTHR Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track UTHR's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked UTHR news questions
- What is the latest UTHR news headline?
- The most recent UTHR headline (Nov 9, 2026) is "United Therapeutics Corporation Announces Participation at Upcoming Investor Conferences". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the UTHR news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What UTHR news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual UTHR options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.